Titre:
  • A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma.
Auteur:Westphal, Manfred; Hilt, D.; Bortey, E.; Delavault, P.; Olivares, R.; Warnke, P; Whittle, IR; Jääskeläinen, J.; Ram, Z.; De Witte, Olivier
Informations sur la publication:Neuro-oncology, 5, 2, page (79-88)
Statut de publication:Publié, 2003-04
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:Adult
Aged
Biocompatible Materials -- therapeutic use
Brain Neoplasms -- drug therapy
Brain Neoplasms -- mortality
Brain Neoplasms -- pathology
Brain Neoplasms -- surgery
Carmustine -- therapeutic use
Delayed-Action Preparations -- therapeutic use
Double-Blind Method
Drug Carriers -- therapeutic use
Drug Implants
Female
Glioma -- drug therapy
Glioma -- mortality
Glioma -- pathology
Glioma -- surgery
Humans
Internationality
Male
Middle Aged
Proportional Hazards Models
Prospective Studies
Regression Analysis
Survival Rate
Note générale:Clinical Trial
Clinical Trial, Phase III
Comparative Study
Journal Article
Multicenter Study
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langue:Anglais
Identificateurs:urn:issn:1522-8517
info:doi/10.1215/S1522-8517-02-00023-6
info:pmid/12672279
PMC1920672